MEDIF News and Press, Medipharm Labs Corp

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of ma...

2026-06-17 15:42:26 ET MediPharm Labs Corp. (LABS:CA) Shareholder/Analyst Call June 17, 2026 11:00 AM EDT... Read the full article on Seeking Alpha For further details see: MediPharm Labs Corp. (LABS:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time). The Board of Directors recommends shareholders vote FOR all director nominees and resolutions, before the 11:00 a.m. (Eastern Time) deadline on Monday, June 15, 2026. Shareholders who have ...

2026-05-13 11:30:48 ET MediPharm Labs Corp. (LABS:CA) Q1 2026 Earnings Call May 13, 2026 10:00 AM EDT Company Participants Greg Hunter - CFO & Interim CEO Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division Pres...

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its first quarter fina...

On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug products and state-licensed medical cannabis from Schedule I to Schedule III of the Controlled Substances Act took effect. MediPharm Labs has already...

2026-03-30 13:47:31 ET As international medical cannabis demand surges, a shift in global regulatory landscapes is creating a distinct advantage for producers with pharmaceutical-grade infrastructure. While the domestic Canadian market has faced persistent headwinds from pricing compression...

2026-03-30 11:52:09 ET MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call March 30, 2026 10:00 AM EDT... Read the full article on Seeking Alpha For further details see: MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript

2026-03-30 08:06:51 ET More on MediPharm Labs Corp. Historical earnings data for MediPharm Labs Corp. Financial information for MediPharm Labs Corp. Read the full article on Seeking Alpha For further details see: MediPharm Labs reports Q4 results

FY 2025 revenue of $45.1 million, an increase of 8% over 2024 International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenue Increased cash balance of $10.8 Million at the end of Q4, up $0.2 million from Q3 2025 Company remains virtually...